EP1594496A4 - Methode et compositions therapeutiques pour administration topique - Google Patents
Methode et compositions therapeutiques pour administration topiqueInfo
- Publication number
- EP1594496A4 EP1594496A4 EP04711191A EP04711191A EP1594496A4 EP 1594496 A4 EP1594496 A4 EP 1594496A4 EP 04711191 A EP04711191 A EP 04711191A EP 04711191 A EP04711191 A EP 04711191A EP 1594496 A4 EP1594496 A4 EP 1594496A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- topical administration
- therapeutic method
- novel therapeutic
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0303600.1A GB0303600D0 (en) | 2003-02-17 | 2003-02-17 | Novel therapeutic method and compositions |
GB0303600 | 2003-02-17 | ||
PCT/US2004/004393 WO2004073627A2 (fr) | 2003-02-17 | 2004-02-13 | Methode et compositions therapeutiques pour administration topique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1594496A2 EP1594496A2 (fr) | 2005-11-16 |
EP1594496A4 true EP1594496A4 (fr) | 2006-05-03 |
Family
ID=9953155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04711191A Withdrawn EP1594496A4 (fr) | 2003-02-17 | 2004-02-13 | Methode et compositions therapeutiques pour administration topique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1594496A4 (fr) |
JP (1) | JP2007525420A (fr) |
GB (1) | GB0303600D0 (fr) |
WO (1) | WO2004073627A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2885491B1 (fr) * | 2005-05-16 | 2020-03-06 | Nutricos Technologies | Traitement de la secheresse keratinique par des glycerides |
FR2897534A1 (fr) * | 2006-02-17 | 2007-08-24 | Galderma Res & Dev | Utilisation du tesaglitazar pour la preparation d'une composition pharmaceutique destinee au traitement des affections dermatologiques |
WO2009086550A1 (fr) * | 2008-01-03 | 2009-07-09 | Abbott Laboratories | Prédiction de l'efficacité à long terme d'un composé dans le traitement du psoriasis |
JP5619027B2 (ja) * | 2009-01-23 | 2014-11-05 | エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft | アレグリタザルを含む医薬組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294580B1 (en) * | 1996-02-28 | 2001-09-25 | Glaxo Wellcome Inc. | Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773075B1 (fr) * | 1997-12-31 | 2000-05-05 | Cird Galderma | Utilisation d'activateurs de ppar-gamma en dermatologie |
WO2002013812A1 (fr) * | 2000-08-17 | 2002-02-21 | Pershadsingh Harrihar A | Traitements de maladies inflammatoires |
US6573287B2 (en) * | 2001-04-12 | 2003-06-03 | Bristo-Myers Squibb Company | 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method |
ATE346601T1 (de) * | 2001-06-20 | 2006-12-15 | Merck Sante Sas | Verwendung von antidiabetika zur herstellung eines vernarbungsfördernden arzneimittels |
-
2003
- 2003-02-17 GB GBGB0303600.1A patent/GB0303600D0/en not_active Ceased
-
2004
- 2004-02-13 JP JP2006503589A patent/JP2007525420A/ja active Pending
- 2004-02-13 EP EP04711191A patent/EP1594496A4/fr not_active Withdrawn
- 2004-02-13 WO PCT/US2004/004393 patent/WO2004073627A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294580B1 (en) * | 1996-02-28 | 2001-09-25 | Glaxo Wellcome Inc. | Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma |
Also Published As
Publication number | Publication date |
---|---|
JP2007525420A (ja) | 2007-09-06 |
WO2004073627A3 (fr) | 2004-11-18 |
EP1594496A2 (fr) | 2005-11-16 |
GB0303600D0 (en) | 2003-03-19 |
WO2004073627A2 (fr) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI345979B (en) | Topical pharmaceutical compositions for the treatment of dermatitis | |
ZA200409332B (en) | Novel methods and compositions for alleviating pain | |
EP1513825A4 (fr) | Medicament anti-tuberculeux: compositions et methodes | |
EP1603543A4 (fr) | Compositions therapeutiques | |
AU2002951833A0 (en) | Compositions and therapeutic methods invloving platinum complexes | |
EP1594959A4 (fr) | Methode therapeutique et compositions destinees a une administration topique | |
EP1648364A4 (fr) | Compositions pharmaceutiques pour application topique | |
EP1648474A4 (fr) | Methodes et compositions pharmaceutiques pour cicatriser des lesions | |
ZA200600025B (en) | Methods and compositions for interferon therapy | |
EP1608385A4 (fr) | Compositions th rapeutiques | |
IL173148A0 (en) | Methods and pharmaceutical compositions for healing wounds | |
GB2392618B (en) | Compositions for therapeutic use | |
GB0229258D0 (en) | Medicinal compositions | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
GB0222945D0 (en) | Therapeutic compositions | |
AU2003282722A8 (en) | Therapeutic compositions | |
EP1600445A4 (fr) | Preparation curative | |
HK1081451A1 (en) | Medicinal composition | |
EP1594496A4 (fr) | Methode et compositions therapeutiques pour administration topique | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
GB0327050D0 (en) | Therapeutic methods compositions and uses | |
ZA200603126B (en) | Pharmaceutical compositions for therapeutic use | |
HK1062274A1 (en) | Medicinal composition | |
AU2003235931A1 (en) | Vintoperol-containing medicinal composition for transdermal administration | |
GB0205826D0 (en) | Therapeutic compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050805 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060321 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 17/00 20060101ALI20060315BHEP Ipc: A61K 31/421 20060101AFI20060315BHEP |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20050805 Extension state: LT Payment date: 20050805 |
|
17Q | First examination report despatched |
Effective date: 20061031 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20090522 |